OGEN Oragenics Inc

Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits.

$0.82
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
05/20/2004
109,646,119
16,243,462
$89,909,818
0.00%
SEC Edgar Online
10-Q
10-K
684023302
US6840233026
BFWK6N7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
2.65
0.00
-156.91%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy